Dr. Silverman is always on the lookout for innovations that can make recovery smoother and safer for our patients. That’s why we’re thrilled to share some exciting news: the FDA has recently approved suzetrigine (Journavx), a first-in-its-class drug that aims to transform how we manage post-operative pain—especially for those healing from foot and ankle surgeries. […]